PMA supplement
P060002 S006: BARD FLAIR ENDOVASCULAR STENT GRAFT
FDA PMA supplement · Normal 180 Day Track No User Fee · Bard Peripheral Vascular
Key facts
| Original PMA | P060002 |
|---|---|
| Supplement number | S006 |
| Supplement type | Normal 180 Day Track No User Fee |
| Reason for the supplement | Postapproval Study Protocol - OSB |
| Trade name | BARD FLAIR ENDOVASCULAR STENT GRAFT |
| Generic name | System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment |
| Applicant | Bard Peripheral Vascular |
| Product code | PFV |
| Received date | Sep 30, 2009 |
| Decision date | May 18, 2010 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: